Shares of German pharmaceutical and cosmetic packaging specialist Gerresheimer rose 5.7% on Friday, lifting the stock to €26.68.
The advance follows an interim leadership transition and preliminary first-quarter 2026 financial results that showed a modest revenue increase but a decline in adjusted earnings before interest, taxes, depreciation and amortization (EBITDA).
Gerresheimer reported preliminary first-quarter revenue of €524 million, up from €519 million in the same period a year earlier on an adjusted basis. Adjusted EBITDA fell to €66 million from €81 million, while the EBITDA margin narrowed to 12.6% from 15.7%. The company attributed the margin compression to a deliberate strategic shift prioritizing cash generation over short-term profitability.
The stock remains well below its 52-week high of €45.24 and has largely traded in the €20 range throughout August.
On August 24, 2026, Gerresheimer confirmed the departure of CEO Uwe Röhrhoff, with Wolf Lehmann and Achim Schalk assuming interim co-leadership responsibilities. The company previously reduced its full-year 2026 revenue guidance to the lower half of a €2.3 billion to €2.4 billion range.
The move comes as broader European equity markets show signs of stabilization, with German mid-cap stocks trading in positive territory and U.S. indices posting gains. Gerresheimer is listed on Germany’s SDAX index.
